Hyderabad: Revenue minister Ponguleti Srinivas Reddy on Monday said that the controversial Dharani portal will be replaced by the Bhu Bharati in April. He said the Bhu Bharati Act will come into ...

Ionis Pharmaceuticals has entered a licence agreement with Sobi in which the latter obtains exclusive rights to commercialise olezarsen intended for familial chylomicronaemia syndrome (FCS ...

Prasar Bharati has signed a mega deal, possibly its biggest-ever media deal, with veteran editor, journalist and news anchor Sudhir Chaudhary for the much-anticipated revival of Doordarshan.

Filmmaker Vikram Bhatt recently reflected on how many of his films, including Ghulam and Awara Paagal Deewana, received an ‘A’ certification from the censor board. Speaking on the Cyrus Says ...

STOCKHOLM, March 31, 2025 /PRNewswire/ -- Swedish Orphan Biovitrum AB (publ) (Sobi®) published its Annual and sustainability report today. The report details the progress Sobi has made in 2024 ...

Rabindranath Tagore-founded Visva-Bharati, the only Central University in West Bengal, has got a new full-time Vice-Chancellor after a long gap of 15 months. Agriculture scientist Probir Kumar ...

About 20 scholars and experts from China will visit Visva-Bharati University to participate in an international seminar on Rabindranath Tagore on April 1 to mark the 75th anniversary of India ...

IDS is a new endotype representing approximately 20 percent of sepsis patients and is characterised by detection of IFNγ (above lower limit of detection) and elevated levels of the chemokine ...

She completed her bachelor's degree in Bengali literature from the University of Dhaka in 1955. She then earned her MA in Bengali from Visva-Bharati in 1957. Khatun later obtained her PhD from ...

STOCKHOLM, March 31, 2025 /PRNewswire/ -- Swedish Orphan Biovitrum AB (publ) (Sobi®) published its Annual and sustainability report today. The report details the progress Sobi has made in 2024 ...

Sobi® (STO: SOBI), today announced a research collaboration involving a new Phase 2a clinical trial for Gamifant® (emapalumab) for the potential treatment of interferon-gamma (IFNγ)-driven sepsis (IDS ...

Ionis Pharmaceuticals (NASDAQ:IONS) has entered into a license agreement under which Sobi receives exclusive rights in countries outside the U.S., Canada and China to commercialize olezarsen as a ...